These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1899321)

  • 1. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
    Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U
    Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
    Giebel LB; Musarella MA; Spritz RA
    J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.
    Giebel LB; Tripathi RK; Strunk KM; Hanifin JM; Jackson CE; King RA; Spritz RA
    Am J Hum Genet; 1991 Jun; 48(6):1159-67. PubMed ID: 1903591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
    Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
    J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
    J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation (delAACT) in the tyrosinase gene in a Cameroonian black with type 1A oculocutaneous albinism.
    Badens C; Courrier S; Aquaron R
    J Dermatol Sci; 2006 May; 42(2):121-4. PubMed ID: 16517127
    [No Abstract]   [Full Text] [Related]  

  • 10. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-allele system in the Korean for MboI-RFLP in exon 1 of the human tyrosinase (TYR) gene.
    Kim DK; Kang KH; Choi IJ
    J Dermatol Sci; 2000 Sep; 24(1):1-3. PubMed ID: 10960773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
    Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
    Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
    Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
    Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59.
    Takeda A; Tomita Y; Matsunaga J; Tagami H; Shibahara S
    J Biol Chem; 1990 Oct; 265(29):17792-7. PubMed ID: 2120217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).
    Lee ST; Nicholls RD; Schnur RE; Guida LC; Lu-Kuo J; Spinner NB; Zackai EH; Spritz RA
    Hum Mol Genet; 1994 Nov; 3(11):2047-51. PubMed ID: 7874125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA; Mentink MM; Oetting WS
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico.
    Oetting WS; Witkop CJ; Brown SA; Colomer R; Fryer JP; Bloom KE; King RA
    Am J Hum Genet; 1993 Jan; 52(1):17-23. PubMed ID: 8434585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.